Insider · CIK 0001706297

Thornton Michael Milos

Reports to the SEC for 1 company · ANN ARBOR, MI

sec.gov

Transactions

Companies

Filings

CIK

0001706297

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-05-18	NDRAENDRA Life Sciences Inc.P Purchase	Chief Technology Officer	PPurchase	+15K sh	$1.65	+$24.8K	34,139
2023-01-30	NDRAENDRA Life Sciences Inc. · Stock OptionsA Award	Chief Technology Officer	AAward	+68.1K sh	—	—	68,066
2022-12-09	NDRAENDRA Life Sciences Inc.P Purchase	Chief Technology Officer	PPurchase	+1,500 sh	$3.40	+$5,100	19,139
2022-08-22	NDRAENDRA Life Sciences Inc.P Purchase	Chief Technology Officer	PPurchase	+20K sh	$0.27	+$5,400	352,775
2022-05-26	NDRAENDRA Life Sciences Inc.P Purchase	Chief Technology Officer	PPurchase	+25K sh	$0.21	+$5,250	332,775
2022-05-18	NDRAENDRA Life Sciences Inc.P Purchase	Chief Technology Officer	PPurchase	+25K sh	$0.22	+$5,500	307,775
2022-03-28	NDRAENDRA Life Sciences Inc. · Stock OptionsA Award	Chief Technology Officer	AAward	+698K sh	—	—	698,102
2021-04-07	NDRAENDRA Life Sciences Inc.S Sale	Chief Technology Officer	SSale	−15K sh	$2.53	−$38K	259,960
2021-04-05	NDRAENDRA Life Sciences Inc. · Stock OptionsA Award	Chief Technology Officer	AAward	+50K sh	—	—	50,000
2021-03-29	NDRAENDRA Life Sciences Inc.S Sale	Chief Technology Officer	SSale	−18.8K sh	$2.37	−$44.4K	274,960
2021-02-11	NDRAENDRA Life Sciences Inc.A Award	Chief Technology Officer	AAward	+22.8K sh	—	—	316,525
2021-01-28	NDRAENDRA Life Sciences Inc.A Award	Chief Technology Officer	AAward	+22.8K sh	—	—	316,525
2020-07-15	NDRAENDRA Life Sciences Inc.X Exercise of In-Money	Chief Technology Officer	XExercise of In-Money	+26K sh	$0.87	+$22.6K	293,710
2020-07-15	NDRAENDRA Life Sciences Inc. · WarrantsX Exercise of In-Money	Chief Technology Officer	XExercise of In-Money	−26K sh	—	—	24,252
2020-06-08	NDRAENDRA Life Sciences Inc.C Conversion	Chief Technology Officer	CConversion	+51.7K sh	$0.87	+$45K	267,710
2020-06-08	NDRAENDRA Life Sciences Inc. · Series A Convertible Preferred StockC Conversion	Chief Technology Officer	CConversion	−43.719 sh	$1143.68	−$50K	0
2020-04-09	NDRAENDRA Life Sciences Inc.A Award	Chief Technology Officer	AAward	+96.2K sh	—	—	215,963
2019-12-11	NDRAENDRA Life Sciences Inc. · Stock option (right to buy)A Award	Chief Technology Officer	AAward	+576K sh	—	—	575,906
2019-12-11	NDRAENDRA Life Sciences Inc. · Series A Convertible Preferred StockA Award	Chief Technology Officer	AAward	+43.719 sh	$1143.68	+$50K	43.719
2019-12-11	NDRAENDRA Life Sciences Inc. · WarrantsA Award	Chief Technology Officer	AAward	+50.3K sh	—	—	50,252
2019-05-16	NDRAENDRA Life Sciences Inc.P Purchase	Chief Technology Officer	PPurchase	+30K sh	$1.13	+$33.9K	119,750
2018-12-13	NDRAENDRA Life Sciences Inc. · Stock OptionsA Award	Chief Technology Officer	AAward	+125K sh	—	—	125,000
2018-11-13	NDRAENDRA Life Sciences Inc.C Conversion	Chief Technology Officer	CConversion	+29.8K sh	$1.68	+$50K	89,750
2018-11-13	NDRAENDRA Life Sciences Inc. · Convertible Promissory NoteC Conversion	Chief Technology Officer	CConversion	—	$50000.00	—	—
2018-06-28	NDRAENDRA Life Sciences Inc. · Convertible Promissory NoteA Award	Chief Technology Officer	AAward	—	$50000.00	—	—
2018-06-28	NDRAENDRA Life Sciences Inc. · WarrantsA Award	Chief Technology Officer	AAward	+12.4K sh	—	—	12,401
2017-06-09	NDRAENDRA Life Sciences Inc. · Stock OptionsA Award	Chief Technology Officer	AAward	+32K sh	—	—	31,960
2017-06-09	NDRAENDRA Life Sciences Inc. · Stock OptionsA Award	Chief Technology Officer	AAward	+32K sh	—	—	31,960
2017-05-12	NDRAENDRA Life Sciences Inc.C Conversion	Chief Technology Officer	CConversion	+55K sh	$1.40	+$77K	59,987
2017-05-12	NDRAENDRA Life Sciences Inc. · Convertible Promissory NoteC Conversion	Chief Technology Officer	CConversion	—	—	—	—
2017-05-12	NDRAENDRA Life Sciences Inc. · Stock OptionsA Award	Chief Technology Officer	AAward	+313K sh	—	—	313,338
2017-05-12	NDRAENDRA Life Sciences Inc. · Stock OptionsA Award	Chief Technology Officer	AAward	+313K sh	—	—	313,338

Recent filings

Accepted (ET)
May 224
Thornton Michael Milos0001209191-23-031298
SEC(opens sec.gov)
Feb 14
Thornton Michael Milos0001209191-23-006047
SEC(opens sec.gov)
Dec 134
Thornton Michael Milos0001209191-22-060895
SEC(opens sec.gov)
Aug 244
Thornton Michael Milos0001209191-22-047298
SEC(opens sec.gov)
May 314
Thornton Michael Milos0001209191-22-032746
SEC(opens sec.gov)
May 234
Thornton Michael Milos0001209191-22-031319
SEC(opens sec.gov)
Mar 304
Thornton Michael Milos0001209191-22-021624
SEC(opens sec.gov)
Sep 224
Thornton Michael Milos0001209191-21-057234
SEC(opens sec.gov)
Apr 304
Thornton Michael Milos0001209191-21-029290
SEC(opens sec.gov)
Apr 74
Thornton Michael Milos0001209191-21-025846
SEC(opens sec.gov)
Jul 164
Thornton Michael Milos0001209191-20-042615
SEC(opens sec.gov)
Jun 104
Thornton Michael Milos0001209191-20-035437
SEC(opens sec.gov)
Apr 134
Thornton Michael Milos0001209191-20-024211
SEC(opens sec.gov)
Dec 114
Thornton Michael Milos0001209191-19-060091
SEC(opens sec.gov)

Companies

ENDRA Life Sciences Inc.Chief Technology OfficerNDRA

Address

3600 GREEN COURT, SUITE 350

ANN ARBOR, MI, 48105